Evotec SE
EVO · NASDAQ
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Evotec SE (EVT) is a German pharmaceutical company focused on drug research and development. The company provides services to pharmaceutical and biotechnology firms in the areas of drug discovery, testing, and drug development. Evotec collaborates with various research institutions and pharmaceutical companies worldwide to identify and develop new drugs for different diseases. The company specializes in areas such as oncology, neurology, metabolic disorders, and infectious diseases. Evotec has a long history of research and innovation in the pharmaceutical industry, and its technologies and expertise are highly regarded in the world of medical research. Evotec SE (EVT) shares may be an attractive investment opportunity for investors interested in the pharmaceutical sector and seeking an investment in a company with a significant role in discovering new drugs and therapeutic approaches.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Christian Wojczewski
Employees
4,553
Headquarters
Hamburg
Upcoming events
Earnings
Upcoming earnings report